Literature DB >> 11806726

Antitumor benzothiazoles. 16. Synthesis and pharmaceutical properties of antitumor 2-(4-aminophenyl)benzothiazole amino acid prodrugs.

Ian Hutchinson1, Sharon A Jennings, B Rao Vishnuvajjala, Andrew D Westwell, Malcolm F G Stevens.   

Abstract

A series of water-soluble L-lysyl- and L-alanyl-amide prodrugs of the lipophilic antitumor 2-(4-aminophenyl)benzothiazoles has been synthesized to address formulation and bioavailability issues related to the desired parenteral administration of the chosen clinical candidate. The prodrugs exhibit the required pharmaceutical properties of good water solubility (in weak acid) and stability at ambient temperature and degradation to free base in vivo. The lysyl-amide of 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole (NSC 710305, 6d) has been selected for phase 1 clinical evaluation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11806726     DOI: 10.1021/jm011025r

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  34 in total

1.  One-step synthesis of azole- and benzazole-based sulfonamides in aqueous media.

Authors:  Hassan Zali-Boeini; Zhaleh Najafi; Bahareh Abtahi; Hajar Golshadi Ghaleshahi
Journal:  Mol Divers       Date:  2015-01-23       Impact factor: 2.943

2.  Characterization of the 4-(benzothiazol-2-yl)phenylnitrenium ion from a putative metabolite of a model antitumor drug.

Authors:  Mrinal Chakraborty; Kyoung Joo Jin; Stephen A Glover; Michael Novak
Journal:  J Org Chem       Date:  2010-08-06       Impact factor: 4.354

3.  Evaluation of the thiazole Schiff bases as β-glucuronidase inhibitors and their in silico studies.

Authors:  Khalid Mohammed Khan; Aneela Karim; Sumayya Saied; Nida Ambreen; Xayale Rustamova; Shagufta Naureen; Sajid Mansoor; Muhammad Ali; Shahnaz Perveen; M Iqbal Choudhary; Guillermo Antonio Morales
Journal:  Mol Divers       Date:  2014-02-18       Impact factor: 2.943

4.  Spectroscopic Studies on the Interaction of Naphthyridines with DNA and Fluorescent Detection of DNA in Agarose Gel.

Authors:  G Mahalakshmi; B Selvakumar; K N Vennila; P Lakshmana Rao; S Madhuri; M Seenivasaperumal; Kuppanagounder P Elango
Journal:  J Fluoresc       Date:  2021-01-03       Impact factor: 2.217

5.  Novel nitrogen-enriched oridonin analogues with thiazole-fused A-ring: protecting group-free synthesis, enhanced anticancer profile, and improved aqueous solubility.

Authors:  Chunyong Ding; Yusong Zhang; Haijun Chen; Zhengduo Yang; Christopher Wild; Lili Chu; Huiling Liu; Qiang Shen; Jia Zhou
Journal:  J Med Chem       Date:  2013-06-19       Impact factor: 7.446

6.  Putative tumor suppressor cytoglobin promotes aryl hydrocarbon receptor ligand-mediated triple negative breast cancer cell death.

Authors:  Leah K Rowland; Petreena S Campbell; Nicole Mavingire; Jonathan V Wooten; Lancelot McLean; Dain Zylstra; Gabriell Thorne; Devin Daly; Kristopher Boyle; Sonya Whang; Juli Unternaehrer; Eileen J Brantley
Journal:  J Cell Biochem       Date:  2018-11-18       Impact factor: 4.429

7.  Indirect and direct detection of the 4-(benzothiazol-2-yl)phenylnitrenium ion from a putative metabolite of a model anti-tumor drug.

Authors:  Mrinal Chakraborty; Kyoung Joo Jin; Samuel C Brewer; Huo-Lei Peng; Matthew S Platz; Michael Novak
Journal:  Org Lett       Date:  2009-11-05       Impact factor: 6.005

8.  3-(Benzothia-zol-2-yl)-3-(prop-2-yn-yl)hex-5-yn-2-one.

Authors:  Yamna Baryala; Abdelfettah Zerzouf; Moussa Salem; El Mokhtar Essassi; Lahcen El Ammari
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-03-17

9.  Synthesis and identification of a new class of (S)-2,6-diamino-4,5,6,7-tetrahydrobenzo[d]thiazole derivatives as potent antileukemic agents.

Authors:  D S Prasanna; C V Kavitha; B Raghava; K Vinaya; S R Ranganatha; Sathees C Raghavan; K S Rangappa
Journal:  Invest New Drugs       Date:  2009-06-10       Impact factor: 3.850

10.  Antitumour 2-(4-aminophenyl)benzothiazoles generate DNA adducts in sensitive tumour cells in vitro and in vivo.

Authors:  C-O Leong; M Gaskell; E A Martin; R T Heydon; P B Farmer; M C Bibby; P A Cooper; J A Double; T D Bradshaw; M F G Stevens
Journal:  Br J Cancer       Date:  2003-02-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.